Kenneth Reay Code - Oct 5, 2021 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Chief Science Officer, Director, 10%+ Owner
Signature
/s/ John R. Browning, Attorney-in-fact
Stock symbol
BLGO
Transactions as of
Oct 5, 2021
Transactions value $
$11,750
Form type
4
Date filed
10/6/2021, 08:54 PM
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLGO Common stock Award $11.7K +61.8K +0.25% $0.19 24.6M Oct 5, 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
F2 Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.
F3 The shares issued are unvested and subject to a Lock-Up Agreement dated as of the issuance date whereby shares vest only upon the earlier of (i) the sale of the Issuer of substantially all of its assets, (ii) the successful commercialization of Issuer's products or technologies as demonstrated by its receipt of at least $3,000,000 in cash, or the recognition of $3,000,000 in revenue, over a 12-month period from the sale of products and/or the license of technology; and (iii) the Company's breach of the employment agreement between the Company and Reporting Person and resulting in Reporting Person's termination.